Mersana Therapeutics, Inc. (MRSN)
28.88
-0.20
(-0.67%)
USD |
NASDAQ |
Dec 29, 12:54
Mersana Therapeutics Shareholders Equity (Quarterly): -59.54M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 422.39M |
| Day One Biopharmaceuticals, Inc. | 450.87M |
| Semler Scientific, Inc. | 459.75M |
| Cue Biopharma, Inc. | 13.25M |
| Scholar Rock Holding Corp. | 245.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.69M |
| Total Liabilities (Quarterly) | 122.22M |
| Debt to Equity Ratio | -0.0385 |
| Current Ratio | 1.386 |
| Net Debt Paydown Yield | 15.52% |